Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healive Safety, Immunogenicity, and Persistence in Children
NCT00534885Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Mar 2006
- Primary completion
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis A vaccine (inactivated) in hepatitis A (HAV), sponsored by Sinovac Biotech Ltd.. Started Mar 2006; status: completed.
02
Drugs
hepatitis A vaccine (inactivated)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00534885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534885.